Larry A Harshyne Selected Research

Larry A Harshyne Research Topics

Disease

11	Neoplasms (Cancer) 01/2023 - 07/2013
4	Squamous Cell Carcinoma of Head and Neck 01/2023 - 07/2020
4	Glioma (Gliomas) 01/2021 - 07/2013
4	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 03/2015
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2021 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 01/2017
2	Central Nervous System Infections (Central Nervous System Infection) 01/2018 - 01/2017
2	Infections 01/2018 - 01/2017
1	Astrocytoma (Pilocytic Astrocytoma) 01/2021
1	Basal Cell Carcinoma (Rodent Ulcer) 07/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2018
1	Central Nervous System Viral Diseases 01/2018
1	Lymphoma (Lymphomas) 01/2018
1	Demyelinating Diseases (Demyelinating Disease) 01/2018
1	Meningitis 01/2017
1	Disease Progression 09/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2016
1	Lung Neoplasms (Lung Cancer) 09/2016
1	Melanoma (Melanoma, Malignant) 09/2016

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 12/2021 - 07/2013
3	NivolumabIBA 01/2023 - 03/2022
3	Desmoglein 2IBA 12/2021 - 01/2017
2	Interleukin-8 (Interleukin 8)IBA 01/2023 - 07/2020
2	Immune Checkpoint InhibitorsIBA 01/2023 - 03/2022
2	VaccinesIBA 04/2015 - 03/2015
2	OligodeoxyribonucleotidesIBA 04/2015 - 03/2015
2	Insulin-Like PeptidesIBA 04/2015 - 03/2015
2	Therapeutic UsesIBA 04/2015 - 03/2015
1	IpilimumabIBA 01/2023
1	Oncogene Proteins (Oncogene Protein)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Tadalafil (Cialis)FDA Link 03/2022
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 03/2022
1	Glycoproteins (Glycoprotein)IBA 12/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021
1	IGV-001IBA 01/2021
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2021
1	Antisense OligonucleotidesIBA 01/2021
1	BetacellulinIBA 07/2020
1	2-bromopalmitateIBA 07/2020
1	early endosome antigen 1IBA 07/2020
1	flotillinsIBA 07/2020
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 07/2020
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 07/2020
1	Proteins (Proteins, Gene)FDA Link 07/2020
1	Tissue Inhibitor of MetalloproteinasesIBA 07/2020
1	MicroRNAs (MicroRNA)IBA 07/2020
1	Green Fluorescent ProteinsIBA 07/2020
1	Interleukin-1 Receptor-Associated KinasesIBA 07/2020
1	ErbB Receptors (EGF Receptor)IBA 07/2020
1	platelet-derived growth factor AIBA 01/2018
1	IntegrinsIBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2017
1	ChemokinesIBA 01/2017
1	pembrolizumabIBA 09/2016
1	Axitinib (AG 013736)IBA 09/2016
1	Monoclonal AntibodiesIBA 09/2016
1	Immunoglobulins (Immunoglobulin)IBA 02/2016
1	Immunoglobulin G (IgG)IBA 02/2016
1	AntigensIBA 03/2015
1	AntibodiesIBA 03/2015
1	InterleukinsIBA 07/2013
1	Interleukin-10 (Interleukin 10)IBA 07/2013

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2018
2	Radiotherapy 01/2023 - 09/2016
2	Immunotherapy 09/2016 - 03/2015
1	Radioimmunotherapy 01/2023
1	Laryngectomy 01/2017
1	Neck Dissection (Radical Neck Dissection) 01/2017